Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FUTIBATINIB vs GADOTERATE MEGLUMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FUTIBATINIB vs GADOTERATE MEGLUMINE: Safety Overview

Metric FUTIBATINIB GADOTERATE MEGLUMINE
Total FAERS Reports 161 3,186
Deaths Reported 38 46
Death Rate 23.6% 1.4%
Hospitalizations 60 736
Average Patient Age 61.8 yrs 47.7 yrs
% Female Patients 51.3% 69.7%
FDA Approval Date Jul 28, 2025 Apr 11, 2022
Manufacturer TAIHO PHARMACEUTICAL CO., LTD. Slate Run Pharmaceuticals, LLC
Route N/A INTRAVENOUS
Marketing Status Prescription Prescription